DeepCOVID: An Operational Deep Learning-driven Framework for Explainable Real-time COVID-19 Forecasting

Alexander Rodríguez; Anika Tabassum; Jiaming Cui; Jiajia Xie; Javen Ho; Pulak Agarwal; Bijaya Adhikari; B. Aditya Prakash

doi:10.1101/2020.09.28.20203109

Abstract

How do we forecast an emerging pandemic in real time in a purely data-driven manner? How to leverage rich heterogeneous data based on various signals such as mobility, testing, and/or disease exposure for forecasting? How to handle noisy data and generate uncertainties in the forecast? In this paper, we present DeepCovid, an operational deep learning framework designed for real-time COVID-19 forecasting. Deep-Covid works well with sparse data and can handle noisy heterogeneous data signals by propagating the uncertainty from the data in a principled manner resulting in meaningful uncertainties in the forecast. The deployed framework also consists of modules for both real-time and retrospective exploratory analysis to enable interpretation of the forecasts. Results from real-time predictions (featured on the CDC website and FiveThirtyEight.com) since April 2020 indicates that our approach is competitive among the methods in the COVID-19 Forecast Hub, especially for short-term predictions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This paper is based on work partially supported by the NSF (Expeditions CCF-1918770, CAREER IIS-2028586, RAPID IIS-2027862, Medium IIS-1955883, NRT DGE-1545362), CDC MInD program, ORNL and funds/computing resources from Georgia Tech and GTRI. B. A. was in part supported by the CDC MInD-Healthcare U01CK000531-Supplement.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

{arodriguezc{at}gatech.edu, jiamingcui1997{at}gatech.edu, jxie{at}gatech.edu, jho67{at}gatech.edu, pulak.agarwal{at}gatech.edu, badityap{at}gatech.edu} anikat1{at}vt.edu, bijaya-adhikari{at}uiowa.edu
Appears in IAAI-21.

Data Availability

All data are publicly available.

https://github.com/CSSEGISandData/COVID-19

https://covidtracking.com/

https://cmu-delphi.github.io/delphi-epidata/

https://www.google.com/covid19/mobility

https://www.apple.com/covid19/mobility

https://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html

https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/04242020/covid-like-illness.html

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.